[Federal Register: May 29, 2001 (Volume 66, Number 103)]
[Page 29152]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Science Advisory Board to the National Center for Toxicological 
Research; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Science Advisory Board to the National Center 
for Toxicological Research (NCTR).
    General Function of the Committee: The board advises the Director, 
NCTR, in establishing, implementing, and evaluating the research 
programs that assist the Commissioner of Food and Drugs (the 
Commissioner) in fulfilling regulatory responsibilities. The board 
provides an extra-agency review in ensuring that the research programs 
at NCTR are scientifically sound and pertinent.
    Date and Time: The meeting will be held on June 11, 2001, 1 p.m. to 
5:30 p.m., and June 12, 2001, 8:30 a.m. to 1 p.m.
    Location: NCTR, Bldg. #12, Conference Center, Jefferson, AR.
    Contact: Leonard M. Schechtman, NCTR (HFT-10), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6696, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12559. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The board will be presented with progress reports on the 
implementation of recommendations made by the board at its last meeting 
on NCTR's research programs in endocrine disrupter knowledge base and 
microbiology. The NCTR director will provide a center update and a 
discussion of future research directions. A proposal will be made to 
the board that it consider establishing a subcommittee on scientific 
opportunities to improve regulatory science through collaboration with 
external stakeholders. A report will be provided to the board on the 
activities of an existing subcommittee with a similar focus (Advisory 
Committee for Pharmaceutical Science, Nonclinical Studies Subcommittee) 
NCTR division directors will discuss the accomplishments and future 
directions for their divisions.
    Procedure: On June 11, 2001, from 1 p.m. to 5:30 p.m., and June 12, 
2001, from 8:30 a.m. to 12 noon, the meeting is open to the public. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the committee. Written submissions 
may be made to the contact person by May 18, 2001. Oral presentations 
from the public will be scheduled between approximately 11 a.m. and 12 
noon on June 12, 2001. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before May 18, 2001, and submit a brief statement of 
the general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication of 
the approximate time requested to make their presentation.
    Closed Committee Deliberations: On June 12, 2001, from 12 noon to 1 
p.m., the meeting will be closed to permit discussion where disclosure 
would constitute a clearly unwarranted invasion of personal privacy (5 
U.S.C. 552b(c)(6)). This portion of the meeting will be closed to 
permit discussion of information concerning individuals associated with 
the research programs at NCTR.
    The Commissioner approves the scheduling of meetings at locations 
outside the Washington, DC area on the basis of the criteria of 21 CFR 
14.22 of FDA's regulations relating to public advisory committees.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 22, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-13378 Filed 5-25-01; 8:45 am]